Patent · US Active

Treprostinil derivative compounds and methods of using same

US10450290B2 · kind B2 · utility

13Cited by

68References

14Claims

0Family size

Assignee

Corsair Pharma, Inc. · US

Inventors

Cyrus K. BECKER · Fremont, US
Meenakshi S. Venkatraman · Fremont, US
Xiaoming Zhang · Beijing, CN

Key dates

Filing date	Nov 13, 2017
Grant date	Oct 22, 2019
Priority date	—
Expiry date	Nov 13, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.